Assessment of whole blood thrombosis in a microfluidic device lined by fixed human endothelium
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The vascular endothelium and shear stress are critical determinants of physiological hemostasis and platelet function in vivo, yet current diagnostic and monitoring devices do not fully incorporate endothelial function under flow in their assessment and, therefore, they can be unreliable and inaccurate. It is challenging to include the endothelium in assays for clinical laboratories or point-of-care settings because living cell cultures are not sufficiently robust. Here, we describe a microfluidic device that is lined by a human endothelium that is chemically fixed, but still retains its ability to modulate hemostasis under continuous flow in vitro even after few days of storage. This device lined with a fixed endothelium supports formation of platelet-rich thrombi in the presence of physiological shear, similar to a living arterial vessel. We demonstrate the potential clinical value of this device by showing that thrombus formation and platelet function can be measured within minutes using a small volume (0.5 mL) of whole blood taken from subjects receiving antiplatelet medications. The inclusion of a fixed endothelial microvessel will lead to biomimetic analytical devices that can potentially be used for diagnostics and point-of-care applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therefore, microfluidic devices (i.e. thrombosis-on-chip devices) are of interest to mimic a range of flows and shear stresses, starting from low (i.e. in veins) to high values (i.e. in arteries) [287–290].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [287]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These devices possess endothelialized lumen that can reliably capture several features of blood vessels such as atherosclerosis (i.e. fatty plaque deposition and formation) and bifurcations (i.e. branches and bends) by changing the channel geometries and flow patterns, ranging from laminar steady flow to pulsatile flow [287–290,295–304].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [287]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Proof-of-concept studies were performed in which the VoC was treated with the inflammatory cytokine tumor necrosis factor (TNF)-α, and patterns of platelet adhesion upon human whole blood perfusion were analysed (Jain et al., 2016).”
From Considering future qualification for regulatory science in the early development of microphysiological systems: a case study of microthrombosis in a Vessel-on-Chip (2024) · cites this paper as Jain et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapid Prototyping of Microfluidic Systems in Poly(dimethylsiloxane)
Duffy, D. C., McDonald, J. C., Schueller, O. J. A., & Whitesides, G. M. (1998) · Analytical Chemistry · doi:10.1021/ac980656z · Cited by 5,288 · cited 4×
“…device design and fabrication The microfluidic device was designed using AutoCAD software, master templates were fabricated by photolithography on Si (100) wafers (University Wafer Corp.) and soft lithography was used to prepare the devices with polydimethylsiloxane (PDMS) (Duffy et al. 1998).”
MethodInfluentialReconstituting organ-level lung functions on a chip
Huh, D., Matthews, B. D., Mammoto, A., Montoya-Zavala, M., Hsin, H. Y., & Ingber, D. E. (2010) · Science · doi:10.1126/science.1188302 · Cited by 4,250 · cited 1×
“…2000) In previous studies, we showed that treatment of living endothelium cultured in microfluidic channels with the inflammatory cytokine TNF-α results in an increase in expression of surface adhesion molecules (e.g., ICAM-1, VCAM-1) within 4 h after addition (Benam et al. 2016; Huh et al. 2010).”
MethodSelf-citationIn vitro microvessels for the study of angiogenesis and thrombosis
Zheng, Y., Chen, J., Craven, M., Choi, N. W., Totorica, S., Diaz-Santana, A., Kermani, P., Hempstead, B., Fischbach-Teschl, C., López, J. A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201240109 · Cited by 894 · cited 1×
“Over the last decade, microfluidic devices that contain hollow channels lined by living endothelium have been exposed to flowing blood to study the basic science of thrombosis in vitro (Colace et al. 2013; Neeves et al. 2013; Tsai et al. 2012; Zheng et al. 2012).”
BackgroundSmall airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro
Benam, K. H., Villenave, R., Lucchesi, C., Varone, A., Hubeau, C., Lee, H.-H., Alves, S. E., Salmon, M., Ferrante, T. C., Weaver, J. C., et al. (2016) · Nature Methods · doi:10.1038/nmeth.3697 · Cited by 816 · cited 1×
“…2000) In previous studies, we showed that treatment of living endothelium cultured in microfluidic channels with the inflammatory cytokine TNF-α results in an increase in expression of surface adhesion molecules (e.g., ICAM-1, VCAM-1) within 4 h after addition (Benam et al. 2016; Huh et al. 2010).”
MethodSelf-citationFalati, S., Gross, P., Merrill-Skoloff, G., Furie, B. C., & Furie, B. (2002) · Nature Medicine · doi:10.1038/nm782 · Cited by 669 · cited 2×
“Also was similar to that of clots formed on living endothelium in vivo, (Cooley 2011; Falati et al. 2002) and significantly different from those formed on bare collagen-coated flow chambers (shape of long tethers) (Colace et al. 2011) Taken together, these results demonstrate that the microfluidic…”
BackgroundResult(2005) · PubMed · Cited by 567
Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans
DAMAS, P., REUTER, A., GYSEN, P., DEMONTY, J., LAMY, M., & FRANCHIMONT, P. (1989) · Critical Care Medicine · doi:10.1097/00003246-198910000-00001 · Cited by 486 · cited 1×
“We first perfused a microdevice containing fixed endothelium that was pretreated with a physiologically relevant dose of TNF-α (5 ng/mL) (Damas et al. 1989; Kim et al. 2014; Schlitt et al. 2004) with whole blood from a healthy donor containing 0 to 100 μg/mL (clinical range ~1–10 μg/mL) (Mascelli…”
MethodBombeli, T., Schwartz, B. R., & Harlan, J. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.3.329 · Cited by 425 · cited 1×
“Notably, these findings also indicate that the fixed surface of the endothelium retains its ability to modulate platelet interactions via the GPIIb/IIIa pathway that is involved in multiple thrombotic and vascular processes, as this is the target of abciximab (Bombeli et al. 1998).”
BackgroundROLE OF ENDOTHELIUM IN THROMBOSIS AND HEMOSTASIS
Wu, M. D., & Thiagarajan, M. D. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.315 · Cited by 384 · cited 2×
“(Alexandru et al. 2012; Lowenberg et al. 2010; Siddiqui et al. 2013; Wu and Thiagarajan 1996) Yet no practical diagnostic assays exist that can measure cross-talk between platelets and inflamed vessel walls in the presence of physiological shear.”
BackgroundCD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-α levels
Blankenberg, S., Espinola-Klein, C., Dopheide, J., Bickel, C., Lackner, K., Iz, M., Meyer, J., Darius, H., Rupprecht, H., Schlitt, A., et al. (2004) · Thrombosis and Haemostasis · doi:10.1160/th04-02-0095 · Cited by 301 · cited 1×
“…containing fixed endothelium that was pretreated with a physiologically relevant dose of TNF-α (5 ng/mL) (Damas et al. 1989; Kim et al. 2014; Schlitt et al. 2004) with whole blood from a healthy donor containing 0 to 100 μg/mL (clinical range ~1–10 μg/mL) (Mascelli et al. 1998) of the…”
Tsai, M., Kita, A., Leach, J., Rounsevell, R., Huang, J. N., Moake, J., Ware, R. E., Fletcher, D. A., & Lam, W. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58753 · Cited by 297 · cited 1×
“Over the last decade, microfluidic devices that contain hollow channels lined by living endothelium have been exposed to flowing blood to study the basic science of thrombosis in vitro (Colace et al. 2013; Neeves et al. 2013; Tsai et al. 2012; Zheng et al. 2012).”
BackgroundMascelli, M. A., Lance, E. T., Damaraju, L., Wagner, C. L., Weisman, H. F., & Jordan, R. E. (1998) · Circulation · doi:10.1161/01.cir.97.17.1680 · Cited by 282 · cited 1×
“…with a physiologically relevant dose of TNF-α (5 ng/mL) (Damas et al. 1989; Kim et al. 2014; Schlitt et al. 2004) with whole blood from a healthy donor containing 0 to 100 μg/mL (clinical range ~1–10 μg/mL) (Mascelli et al. 1998) of the antiplatelet GP IIb/IIIa antagonist, abciximab (ReoPro®).”
MethodIdentification of platelet function defects by multi-parameter assessment of thrombus formation
de Witt, S. M., Swieringa, F., Cavill, R., Lamers, M. M. E., van Kruchten, R., Mastenbroek, T., Baaten, C., Coort, S., Pugh, N., Schulz, A., et al. (2014) · Nature Communications · doi:10.1038/ncomms5257 · Cited by 239 · cited 1×
“…formation and platelet adhesion have been visualized when flowing blood contacts various homogeneous relevant molecular ligands in vitro, (de Witt et al. 2014) but none of these ligands induce formation of thrombi with a morphology that mimic clots observed on the endothelial surface in…”
BackgroundCATTANEO, M., HAYWARD, C. P. M., MOFFAT, K. A., PUGLIANO, M. T., LIU, Y., & MICHELSON, A. D. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03458.x · Cited by 205 · cited 1×
“(Cattaneo et al. 2009).”
Self-citationProbing nanoparticle translocation across the permeable endothelium in experimental atherosclerosis
Kim, Y., Lobatto, M. E., Kawahara, T., Lee Chung, B., Mieszawska, A. J., Sanchez-Gaytan, B. L., Fay, F., Senders, M. L., Calcagno, C., Becraft, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322725111 · Cited by 189 · cited 1×
“…perfused a microdevice containing fixed endothelium that was pretreated with a physiologically relevant dose of TNF-α (5 ng/mL) (Damas et al. 1989; Kim et al. 2014; Schlitt et al. 2004) with whole blood from a healthy donor containing 0 to 100 μg/mL (clinical range ~1–10 μg/mL) (Mascelli et al.…”
MethodJain, A., Graveline, A., Waterhouse, A., Vernet, A., Flaumenhaft, R., & Ingber, D. E. (2016) · Nature Communications · doi:10.1038/ncomms10176 · Cited by 182 · cited 1×
“After 2 min, 100 mM calcium (CaCl2) and 75 mM magnesium (MgCl2) were added to the blood in the reservoir (1: 10 ratio) to restore coagulation-activated blood clotting (Jain et al. 2016; Neeves et al. 2014).”
MethodSelf-citationStalker, T. J., Welsh, J. D., Tomaiuolo, M., Wu, J., Colace, T. V., Diamond, S. L., & Brass, L. F. (2014) · Blood · doi:10.1182/blood-2014-01-550319 · Cited by 181 · cited 1×
“The morphology and adhesion pattern (Movie 2) of these thrombi (shape of a teardrop containing a core and a surrounding shell) (Stalker et al. 2014).”
BackgroundTHE PIVOTAL ROLE OF THE ENDOTHELIUM IN HAEMOSTASIS AND THROMBOSIS
Verhamme, P. B., & Hoylaerts, M. (2006) · Acta Clinica Belgica · doi:10.1179/acb.2006.036 · Cited by 155 · cited 1×
“1h), which mediate thrombus formation induced by TNF-α by promoting adhesion of blood cells and platelets (Sagripanti and Carpi 2000; Verhamme and Hoylaerts 2006; Wu and Thiagarajan 1996).”
Microfluidics and Coagulation Biology
Colace, T. V., Tormoen, G. W., McCarty, O. J. T., & Diamond, S. L. (2013) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071812-152406 · Cited by 124 · cited 1×
“Over the last decade, microfluidic devices that contain hollow channels lined by living endothelium have been exposed to flowing blood to study the basic science of thrombosis in vitro (Colace et al. 2013; Neeves et al. 2013; Tsai et al. 2012; Zheng et al. 2012).”
BackgroundAntithrombotic and prothrombotic activities of the vascular endothelium
Sagripanti, A., & Carpi, A. (2000) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(00)88861-7 · Cited by 90 · cited 2×
“(Sagripanti and Carpi 2000) In previous studies, we showed that treatment of living endothelium cultured in microfluidic channels with the inflammatory cytokine TNF-α results in an increase in expression of surface adhesion molecules (e.g., ICAM-1, VCAM-1) within 4 h after addition (Benam et al.…”
Platelet-vessel wall interaction in health and disease.
Löwenberg, E. C., Meijers, J. C. M., & Levi, M. M. (2010) · PubMed · Cited by 86
Microfluidic technology as an emerging clinical tool to evaluate thrombosis and hemostasis
Branchford, B. R., Ng, C. J., Neeves, K. B., & Paola, J. D. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.05.012 · Cited by 77 · cited 1×
“…than coagulation assays carried out in solution, these devices still fail to capture the dynamic physiological interplay between endothelial cells, platelets and fluid shear stress that are critical for control of blood clotting in inflammatory diseases (Branchford et al. 2015; Neeves et al. 2013).”
BackgroundIn Vivo Fluorescence Imaging of Large-Vessel Thrombosis in Mice
Cooley, B. C. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.225334 · Cited by 74 · cited 2×
“Also was similar to that of clots formed on living endothelium in vivo, (Cooley 2011; Falati et al. 2002) and significantly different from those formed on bare collagen-coated flow chambers (shape of long tethers) (Colace et al. 2011) Taken together, these results demonstrate that the microfluidic…”
BackgroundResultPlatelet dysfunction in vascular pathologies and how can it be treated
Alexandru, N., Popov, D., & Georgescu, A. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.09.026 · Cited by 67 · cited 1×
“(Alexandru et al. 2012; Lowenberg et al. 2010; Siddiqui et al. 2013; Wu and Thiagarajan 1996) Yet no practical diagnostic assays exist that can measure cross-talk between platelets and inflamed vessel walls in the presence of physiological shear.”
BackgroundPlatelets and Atherothrombosis: Causes, Targets and Treatments for Thrombosis
Siddiqui, T., S., A. K., & Dikshit, D. K. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320220004 · Cited by 62
Neeves, K. B., Onasoga, A. A., & Wufsus, A. R. (2013) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283642186 · Cited by 59 · cited 2×
“…than coagulation assays carried out in solution, these devices still fail to capture the dynamic physiological interplay between endothelial cells, platelets and fluid shear stress that are critical for control of blood clotting in inflammatory diseases (Branchford et al. 2015; Neeves et al. 2013).”
BackgroundLian, Q., Chow, Y., Esteban, M., Pei, D., & Tse, H.-F. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-05-0269 · Cited by 55 · cited 1×
“*P < 0.05 diagnostics and advancing personalized medicine (Lian et al. 2010; Nelson and Terzic 2011).”
BackgroundInfluentialInduced Pluripotent Stem Cells: An Emerging Theranostics Platform
Nelson, T. J., & Terzic, A. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.304 · Cited by 37 · cited 1×
“*P < 0.05 diagnostics and advancing personalized medicine (Lian et al. 2010; Nelson and Terzic 2011).”
BackgroundInfluentialPrice, M. J., Parise, H., Gurbel, P. A., & Dahlen, J. R. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-08-0608 · Cited by 33 · cited 1×
“…of individual signaling components (e.g., collagen activation pathways), the results obtained so far with those assays correlate poorly with clinical outcomes (Dahlen et al. 2012) likely because thrombosis associated with most diseases is related more to inflammatory changes than to wall injury.”
Analysis of Morphology of Platelet Aggregates Formed on Collagen Under Laminar Blood Flow
Colace, T. V., Falls, E. M., Zheng, X. L., & Diamond, S. L. (2010) · Annals of Biomedical Engineering · doi:10.1007/s10439-010-0182-4 · Cited by 32 · cited 1×
“…vivo, (Cooley 2011; Falati et al. 2002) and significantly different from those formed on bare collagen-coated flow chambers (shape of long tethers) (Colace et al. 2011) Taken together, these results demonstrate that the microfluidic device lined by fixed human endothelium is capable of reproducing…”
BackgroundNeeves, K. B., McCarty, O. J. T., Reininger, A. J., Sugimoto, M., & King, M. R. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12482 · Cited by 29 · cited 2×
“…in cytokine-stimulated endothelium, the measurements obtained using this device also might be more indicative for thrombus formation on an inflamed endothelium as might be found, for example, in an atherosclerotic plaque (Neeves et al. 2014), than those obtained with conventional hemostasis assays.”
MethodRossi, F., Rossi, E., Pareti, F. I., Colli, S., Tremoli, E., & Gallo, L. (2001) · PubMed · Cited by 21
Research works printed but not linked: 3
- Lowenberg EC Meijers JC Levi M Neth. J. Med. 2010 68 242 20558854
- Papaioannou TG Stefanadis C Hell. J. Cardiol. HJC Hellēnikē Kardiologikē Epitheōrēsē 2005 46 9 15807389
- Rossi F Rossi E Pareti FI Colli S Tremoli E Gallo L Haematologica 2001 86 192 11224490
Cited by
Point-of-Care Diagnostics: Recent Developments in a Connected Age
Nayak, S., Blumenfeld, N. R., Laksanasopin, T., & Sia, S. K. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04630 · Cited by 508
Jain, A., Barrile, R., van der Meer, A., Mammoto, A., Mammoto, T., De Ceunynck, K., Aisiku, O., Otieno, M., Louden, C., Hamilton, G., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.742 · Cited by 325
“However, when the endothelium was stimulated with the inflammatory cytokine, tumor necrosis factor-a (TNF-a; 100 ng mL) prior to initiating blood flow, the inflamed vascular endothelium promoted rapid platelet recruitment and thrombus formation (Figure 2a, bottom and Supplementary Movie S4), as occurs within inflamed…”
BackgroundSelf-citationMarx, U. (2020) · ALTEX · doi:10.14573/altex.2001241 · Cited by 218
“…Cytostretch, a silicon-based modular customizable organ-on-chip platform (Gaio et al., 2016); thrombosis-on-chip model (Westein et al., 2013; Jain et al., 2016; Costa et al., 2017) and prediction of toxic side-effects (Barrile et al., 2018); high-throughput model for perfused 3D angiogenic…”
BackgroundSelf-citationShakeri, A., Khan, S., & Didar, T. F. (2021) · Lab on a Chip · doi:10.1039/d1lc00288k · Cited by 312
Personalised organs-on-chips: functional testing for precision medicine
van den Berg, A., Mummery, C. L., Passier, R., & van der Meer, A. D. (2019) · Lab on a Chip · doi:10.1039/c8lc00827b · Cited by 270
Metadata
- Authors
- Jain, A., van der Meer, A. D., Papa, A.-L., Barrile, R., Lai, A., Schlechter, B. L., Otieno, M. A., Louden, C. S., Hamilton, G. A., Michelson, A. D., Frelinger, A. L., & Ingber, D. E.
- Affiliations
- Boston Children's Hospital (US)
- Harvard University (US)
- Cedars-Sinai Medical Center (US)
- Carnegie Mellon University (US)
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Ingber, Donald E.
- ORCID
- Venue
- Biomedical Microdevices
- Published
- 2016-07-27
- Volume
- 18
- Issue
- 4
- Pages
- 73-73
- ISSN
- 1387-2176 (ISSN-L)
- 1572-8781
- PMC
- PMC4963439
- OpenAlex
- W2501166177
- Cited by
- 148
- References
- 32
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 18 · 2023: 12 · 2022: 11 · 2021: 22 · 2020: 17 · 2019: 15 · 2018: 17 · 2017: 15 · 2016: 1
- FWCI
- 15.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Biomedical Microdevices (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Twente Research Information (submittedVersion, cc-by)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- University of Twente Research Information (submittedVersion, other-oa)
- Funders
- Defense Advanced Research Projects Agency (N66001-11-1-4180, HR0011-13-C-0025)
- Janssen Pharmaceuticals
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Keywords
- microfluidics, platelet function, shear stress, hemostasis, platelet-rich thrombus, antiplatelet agents, point-of-care testing
- MeSH terms
- Blood Platelets, Endothelium, Vascular, Fibrin, Humans, Platelet Aggregation Inhibitors, Stress, Mechanical, Thrombosis, Point-of-Care Systems, Endothelial Cells, Lab-On-A-Chip Devices, Human Umbilical Vein Endothelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.